
Corporate M&A
Joint Ventures
Corporate Carve-Outs
Life Sciences
Chemicals
Automotive
Digital Industries
Dr. Barbara Keil is a Partner at Freshfields in Munich, specializing in multijurisdictional M&A, joint ventures, and corporate carve-out transactions. With extensive experience in sectors such as life sciences, chemicals, automotive, and digital industries, Barbara is adept at navigating complex negotiations and deal scenarios. She regularly advises on large-scale transactions, spin-offs, and group-wide reorganizations, providing strategic guidance to her clients. Barbara's expertise extends to critical commercial contracts, including feedstock supply and cooperation agreements, which are pivotal to successful mergers and joint ventures. Fluent in German, English, French, and Spanish, she brings a global perspective to her practice.
Barbara's representative experience includes advising:

- AURELIUS acquired the target/assets from Xylem Inc. in a acquisition on not available. - Deal value was 3500000000 Sector: Smart Metering; Location: Global. - On the acquirer side, not available advised, led by Barbara Keil, Claire James, David Beutel, Elizabeth Oberholzer, Lori Goodman, Philipp Dohnke, Sarah Katz, Thomas Granetzny, Vinita Kailasanath.
Oct 02 2025
4B
Private Equity

Partner
2016 – 2023
Partner
2023 – Unknown

- 3M acted as the seller in this Spin-off transaction. - The divestment involved assets operating in the Healthcare sector. - The transaction was announced on 08 Apr 2024 with a reported value of 82000000000.0.
Apr 08 2024
82B
M&A
Aug 24

1 min